1.The Lao initiative on access to treatment for epilepsy
Hubert Barennes, Aina Nirina Harimanana ; Somchit Vorachit ; Phetvongsinh Chivorakoun
Neurology Asia 2011;16(Supplement 1):59-61
In Lao PDR research conducted over the last 7 years has highlighted the diffi cult challenges that
the 52,000 patients living with epilepsy (PWE) have to face. Mortality and morbidity is high among
untreated patients. The treatment gap is 90% or more. The highly traditional and poor knowledge of
the disease and its treatment, low trust in modern treatment, restricted access to anti-epileptic drugs
(phenobarbital is the fi rst line drug), and ignorance of requirement for long term treatment explain
the high treatment gap. Stigma, misconceptions, and fear of the disease are common. Knowledge of
medical staffs regarding epilepsy diagnosis and treatment is poor. The neurology investigational facilities
are basic and mainly concentrated in the capital city. Using lessons from program of neighboring
countries, the authors have been developing a step-by-step treatment intervention project since 2009.
The intervention was adapted to the local constraints and a limited budget, which demanded regular
feedbacks, analysis and reorientation of the activities.
2.Lao Association for Patient with Epilepsy: Report of activity 2011-2014
Phetvongsinh CHIVORAKOUN ; Vimalay SOUVONG ; Somchit VORACHIT ; Vatthanaphone LATTHAPHASAVANG ; Ketmany PHETSIRISENG ; Philaysak NAPHAYVONG
Neurology Asia 2015;20(3):385-387
In Lao PDR, the care of patients with epilepsy faces many challenges. There are around 50,000 people
living with epilepsy (PWE) but only 10% have access to antiepileptic medication. The mortality is
high among untreated PWE. Misconception about the disease and stigma are common in the general
population. The availability of antiepileptic medication is poor. Knowledge on epilepsy among health
personnel is poor. Improvement in the management of epilepsy in Lao PDR requires training of health
workers on epilepsy, a system to provide antiepileptic drugs and improvement of knowledge on the
causes and effective treatment of epilepsy among PWE and the public. The Lao Association for
Patients with Epilepsy (APE) was established in 2011 with four main activities: organizing scientific
conferences on epilepsy in Laos; providing three days training on epilepsy to health personal at both
provincial and district levels; supporting the provision of antiepileptic drugs through a revolving
drug fund at provincial and district hospitals; and promoting the dissemination of information on
epilepsy to the public. Up to now, 31 health professionals among 52 who were trained on epilepsy
provide consultations at both provincial and the district levels. A total of 129,200 tablets of a first
line antiepileptic drug (phenobarbital) have been provided to provincial and district hospitals. An
estimated 1,112 PWE are currently under treatment. There is a daily information campaign through
the media; pamphlets and posters are disseminated at epilepsy clinics. A Lao medical network has
been established that will improve access to treatment by PWE.
3.Lao Association for Patient with Epilepsy: Report of activity 2011-2014
Phetvongsinh Chivorakoun ; Vimalay Souvong ; Somchit Vorachit ; Vatthanaphone Latthaphasavang ; Ketmany Phetsiriseng ; Philaysak Naphayvong
Neurology Asia 2015;20(4):385-387
In Lao PDR, the care of patients with epilepsy faces many challenges. There are around 50,000 people
living with epilepsy (PWE) but only 10% have access to antiepileptic medication. The mortality is
high among untreated PWE. Misconception about the disease and stigma are common in the general
population. The availability of antiepileptic medication is poor. Knowledge on epilepsy among health
personnel is poor. Improvement in the management of epilepsy in Lao PDR requires training of health
workers on epilepsy, a system to provide antiepileptic drugs and improvement of knowledge on the
causes and effective treatment of epilepsy among PWE and the public. The Lao Association for
Patients with Epilepsy (APE) was established in 2011 with four main activities: organizing scientific
conferences on epilepsy in Laos; providing three days training on epilepsy to health personal at both
provincial and district levels; supporting the provision of antiepileptic drugs through a revolving
drug fund at provincial and district hospitals; and promoting the dissemination of information on
epilepsy to the public. Up to now, 31 health professionals among 52 who were trained on epilepsy
provide consultations at both provincial and the district levels. A total of 129,200 tablets of a first
line antiepileptic drug (phenobarbital) have been provided to provincial and district hospitals. An
estimated 1,112 PWE are currently under treatment. There is a daily information campaign through
the media; pamphlets and posters are disseminated at epilepsy clinics. A Lao medical network has
been established that will improve access to treatment by PWE.
Epilepsy